Aetna And Medtronic, Inc. Collaborate To Help Members Take Better Control Of Type 2 Diabetes

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

HARTFORD, Conn. & MINNEAPOLIS--(BUSINESS WIRE)--Beginning this month, Aetna (NYSE: AET) and Medtronic, Inc. (NYSE: MDT) will work with doctors in a new program to reach up to 300 fully insured members with uncontrolled type 2 diabetes who may improve their health using insulin pump therapy. Eligible members will receive targeted education, case management and other patient support to help control blood sugar, which also may lower their health care costs. Information gathered from the program also is expected to help doctors and other health care providers more easily identify and support those who can benefit most from this therapy.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC